Subchronic toxicity evaluation of aloesin

Regulatory Toxicology and Pharmacology

Volumn 61, Issue 2, 2011, Pages 161-171

  Lynch, Barry ^a   Simon, Ryan ^a   Roberts, Ashley ^a  

^a Cantox Health Sciences International   (Canada)

Author keywords

Aloe ferox; Aloesin; Subchronic rat; Toxicity

Indexed keywords

ALOESIN; CHROMONE DERIVATIVE; KETONE; UNCLASSIFIED DRUG;

ALOE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FLUID INTAKE; FOOD INTAKE; HEMATOLOGICAL PARAMETERS; MALE; MORTALITY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; EYE; FEMALE; GLUCOSIDES; KETONES; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN;

ALOE; ALOE FEROX; RATTUS;

EID: 80053612505     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.07.005     Document Type: Article

References (33)

1. Ajabnoor M.A. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J. Ethnopharmacol. 1990, 28:215-220.
2. Al-Awadi F.M., Gumaa K.A. Studies on the activity of individual plants of an antidiabetic plant mixture. Acta Diabetol. Lat. 1987, 24:37041.
3. Andersen F.A. Final report on the safety assessment of Aloe and ongensis extract, Aloe andongensis leaf juice, Aloe arborescens leaf extract, Aloe arborescens leaf juice, Aloe arborescens leaf protoplasts, Aloe barbadensis flower extract, Aloe barbadensis leaf, Aloe barbadensis leaf extract, Aloe barbadensis leaf juice, Aloe barbadensis leaf polysaccharides, Aloe barbadensis leaf water, Aloe ferox leaf extract, Aloe ferox leaf juice, and Aloe ferox leaf juice extract (Cosmetic Ingredient Review Expert Panel, Washington, DC). Int. J. Toxicol. 2007, 26:1-50.
4. Baek M., Jeong J.H., Kim D.H. Determination of aloesin in rat plasma using a column-switching high-performance liquid chromatographic assay. J. Chromatogr. B Biomed. Sci. Appl. 2001, 754:121-126.
5. Boudreau M.D., Beland F.A. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2006, 24:103-154.
6. Brown J.P., Dietrich P.S. Mutagenicity of anthraquinone and benzanthrone derivates in the Salmonella/microsome test: activation of anthraquinone glycosides by enzymic extracts of rat cecal bacteria. Mutat. Res. 1979, 66:9-24.
7. Bunyapraphatsara N., Yongchaiyuda S., Rugpitarangsi V., Chokechaijaroenporn O. Anti-diabetic effect of Aloe vera juice. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996, 3:245-248.
8. Che Q.-M., Akao T., Hattori M., Kobashi K., Namba T. Metabolism of aloesin and related compounds by human intestinal bacteria: a bacterial cleavage of the C-glucosyl bond and the subsequent reduction of the acetonyl side chain. Chem. Pharm. Bull. 1991, 39:704-708.
9. Devaraj S., Jialal R., Jialal I., Rockwood J. A pilot randomized placebo controlled trial of 2 Aloe vera supplements in patients with pre-diabetes/metabolic syndrome). Planta Med. 2008, 74:32. (abstract SL77).
10. Dixit V.P., Joshi S. Effect of Aloe barbedensis and clofibrate on serum lipids in triton-induced hyperlipidaemia in Presbytis monkeys. Indian J. Med. Res. 1983, 78:417-421.
11. FDA, 2010. Part 172 - Food additives permitted for direct addition to food for human consumption. Subpart F. Flavoring Agents and Related Substances. Section §172.510 - Aloe. In: US Code of Federal Regulation (CFR. Title 21 Food and Drugs (Food and Drug Administration). Government Printing Office, Washington, DC. Available from: (Accessed 6 May 2011). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm.
12. Fogleman R.W., Shellenberger T.E., Balmer M.F., Carpenter R.H., McAnalley B.H. Subchronic oral administration of acemannan in the rat and dog. Vet. Hum. Toxicol. 1992, 34:144-147.
13. Ghannam N., Kingston M., Al-Meshaal I.A., Tariq M., Parman N.S., Woodhouse N. The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm. Res. 1986, 24:288-294.
14. Giknis, M.L.A., Clifford, C.B.,2006. Clinical Laboratory Parameters for Crl:CD(SD) Rats. Charles River Laboratories, Wilmington, MA. Available from: (Accessed 6 May 2011). http://www.criver.com/SiteCollectionDocuments/rm_rm_r_clinical_parameters_cd_rat_06.pdf.
15. Han Z.Z., Xu H.D., Kim K.H., Ahn T.H., Bae J.S., Lee J.Y., Gil K.H., Lee J.Y., Woo S.J., Yoo H.J., Lee H.K., Kim K.H., Park C.K., Zhang H.S., Song S.W. Reference data of the main physiological parameters in control Sprague-Dawley rats from pre-clinical toxicity studies. Lab. Anim. Res. 2010, 26:153-164.
16. Heidemaan A., Miltenburger H.G., Mengs U. The genotoxicity of Senna. Pharmacology 1993, 47:179-186.
17. Heidemaan A., Voelkner W., Mengs U. Genotoxicity of aloe emodin in vitro and in vivo. Mutat. Res. 1996, 367:123-133.
18. Kim K., Kim H., Kwon J., Lee S., Kong H., Im S.A., Lee Y.H., Lee Y.R., Oh S.T., Jo T.H., Park Y.I., Lee C.K., Kim K. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine 2009, 16:856-863.
19. Kong H., Lee S., Shin S., Kwon J., Jo T.H., Shin E., Shim K.-S., Park Y.-I., Lee C.-K., Kim K. Down-regulation of adipogenesis and hyperglycemia in diet-induced obesity mouse model by aloe qdm. Biomol. Ther. (Seoul). 2010, 18:336-342.
20. Lee K.M., Reed L.L., Bove D.L., Dill J.A. Effects of water dilution, housing and food on rat urine collected from the metabolism cage. Lab. Anim. Sci. 1998, 48:520-525.
21. Lynch, B. Simon, R., Roberts, A., 2011. In vitro and in vivo assessment of the genotoxic activity of aloesin. Food Chem. Toxicol.
22. Matsuzawa, T., Inoue, H., 1999. Biological Reference Data on CD(SD)IGS Rats - 1999. CD(SD)IGS Study Group, Yokohama, Japan. Available from: (Accessed 6 May 2011). http://www.crj.co.jp/pdf/info_common/45/2602977/Biological%20Reference%20Data%20on%20CD(SD)%20Rats%201999.pdf.
23. NTP, 2001. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Emodin (CAS No. 518-82-1) in F344N Rats (Feed Studies). NTP Technical report no. 493. Department of Health and Human Services, Public Health Service, National Institutes of Health. National Toxicology Program (NTP), Research Triangle Park, NC. Available from: (Accessed 6 May 2011). http://ntp.niehs.nih.gov/?objectid=070AF4A8-AF43-7377-A473662E6EA1FB05.
24. NTP, 2011. NTP Technical Report on the Toxicology and Carcinogenesis Studies of a Nondecolorized Whole Leaf Extract of Aloe Barbadensis Miller (Aloe Vera) Emodin in F344N Rats and B6C3F1 Mice (Drinking Water Study). NTP Technical Report no 577. Department of Health and Human Services, Public Health Service, National Institutes of Health. National Toxicology Program (NTP), Research Triangle Park, NC. Available from: http://ntp.niehs.nih.gov/Ntp/About_Ntp/Trpanel/2011/April/DraftTR577.Pdf.
25. Okyar A., Can A., Akev N., Baktir G., Sütlüpinar N. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother. Res. 2001, 15:157-161.
26. Paes-Leme A.A., Motta E.S., De Mattos J.C., Dantas F.J., Bezerra R.J., Caldeira-de-Araujo A. Assessment of Aloe vera (L.) genotoxic potential on Escherichia coli and plasmid DNA. J. Ethnopharmacol 2005, 102:197-201.
27. Park M.Y., Kwon H.J., Sung M.K. Intestinal absorption of aloin, aloe-emodin, and aloesin; a comparative study using two in vitro absorption models. Nutr. Res. Pract. 2009, 3:9-14.
28. Pérez Y.Y., Jiménez-Ferrer E., Zamilpa A., Hernández-Valencia M., Alarcón-Aguilar F.J., Tortoriello J., Román-Ramos R. Effect of a polyphenol-rich extract from Aloe vera gel on experimentally induced insulin resistance in mice. Am. J. Clin. Med. 2007, 35:1037-1046.
29. Rajasekaran S., Sivagnanam K., Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol. Rep. 2005, 57:90-96.
30. Sibuyi N.R.S., Katerere D.R., Boboyi T., Madiehe A.M. Dietary supplementation with Aloe ferox extracts reverses obesity in rats. S. Afr. J. Bot. 2007, 73:336. (abstract).
31. Steenkamp V., Stewart M.J. Medicinal applications and toxicological activities of Aloe products. Pharm. Biol. 2007, 45:411-420.
32. Williams L.D., Burdock G.A., Shin E., Kim S., Jo T.H., Jones K.N., Matulka R.A. Safety studies conducted on a proprietary high-purity Aloe vera inner leaf fillet preparation, Qmatrix. Regul. Toxicol. Pharmacol. 2010, 57(1):90-98.
33. Yiman M., Zhao J., Tseng-Crank J., Brownell L., Devaraj S., Jialal R., Jialal I., Rockwood J., Ma W., Padmapriya A., Jia Q. A novel standardized chomone extract (UP780) from Aloe regulated adiponectin production and improved insulin resistance. Planta Med. 2008, 74:32. [abstract SL78].